Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: Overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease

Virchows Archiv

Volumn 446, Issue 6, 2005, Pages 626-633

  Shiohara, Shigeki ^a   Shiozawa, Tanri ^a   Miyamoto, Tsutomu ^a   Feng, Yu Zhen ^a   Kashima, Hiroyasu ^a   Kurai, Miyuki ^a   Suzuki, Akihisa ^a   Konishi, Ikuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Cyclin; Immunohistochemistry; Ki 67; p53

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 21544481159     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-1252-0     Document Type: Article

References (44)

1. Akasofu M, Oda Y (1995) Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Virchows Arch 425:593-602
2. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH (2001) Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81:341-347
3. Barnes DM (1997) Cyclin D1 in mammary carcinoma. J Pathol 181:267-269
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802
5. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265
6. Brown DC, Cole D, Gatter KC, Mason DY (1988) Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. Br J Cancer 57:178-181
7. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88:1361-1368
8. Cattani P, Hohaus S, Bellacosa A, Genuardi M, Cavallo S, Rovella V, Almadori G, Cadoni G, Galli J, Maurizi M, Fadda G, Neri G (1998) Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 4:2585-2589
9. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC (2000) Prognostic value of p53 expression in stage IB1 cervical carcinoma. Gynecol Obstet Invest 49:266-271
10. Cheng WF, Chen CA, Lee CN, Wei LH, Hsieh FJ, Hsieh CY (2000) Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol 6:721-726
11. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ (2003) P63 and EGFR as prognostic predictors in stage IIB radiationtreated cervical squamous cell carcinoma. Gynecol Oncol 91:346-353
12. Dictor M, Ehinger M, Mertens F, Akervall J, Wennerberg J (1999) Abnormal cell cycle regulation in malignancy. Am J Clin Pathol 112:S40-S52
13. Dong Y, Sui L, Tai Y, Sugimoto K, Hirao T, Tokuda M (2000) Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clin Cancer Res 6:4253-4258
14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710-1715
15. Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 54:4285-4288
16. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK (1993) A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572-1575
17. Ho DM, Hsu CY, Chiang H (2000) MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 76:97-102
18. Hsieh JK, Yap D, O'Connor DJ, Fogal V, Fallis L, Chan F, Zhong S, Lu X (2002) Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 22:78-93
19. Hui AM, Li X, Shi YZ, Takayama T, Torzilli G, Makuuchi M (2000) Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 6:4272-4277
20. Hunt CR, Hale RJ, Buckley CH, Hunt J (1996) p53 expression in carcinoma of the cervix. J Clin Pathol 49:971-974
21. Isacson C, Kessis TD, Hedrick L, Cho KR (1996) Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 56:669-674
22. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S (1998) Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 82:1709-1719
23. Krivak TC, McBroom JW, Elkas JC (2002) Cervical and vaginal cancer. In: Berek JS (ed) Novak's gynecology, 13th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1199-1211
24. Krtolica A, Ludlow JW (1996) Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 56:1168-1173
25. Krtolica A, Krucher NA, Ludlow JW (1999) Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer 80:1875-1883
26. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Bahn A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975-978
27. Michalides R, van Tinteren H, Balkenende A, Vermorken JB, Benraadt J, Huldij J, van Diest P (2002) Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br J Cancer 86:402-408
28. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Ohga T, Sugimachi K (2002) Cyclin A expression in superficial squamous cell carcinoma of the esophagus and coexisting infiltrated lymphocyte follicle. Cancer Lett 188:221-229
29. Oka K, Arai T (1996) MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. Int J Gynecol Pathol 15:23-27
30. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225
31. Sherr CJ (1993) Mammalian Gl cyclins. Cell 73:1059-1065
32. Sherr CJ (1994) G1 phase progression: cyclin on cue. Cell 79:551-555
33. Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I (2003) Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 34:471-478
34. Shioazawa T, Li SF, Nakayama K, Nikaido T, Fujii S (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 2:745-752
35. Skomedal H, Kristensen GB, Lie AK, Holm R (1999) Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 73:223-228
36. Southern SA, Herrington CS (1998) Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res 58:2941-2945
37. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W (2002) Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94:2874-881
38. Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M, Kitajima M (1997) Altered p16/MTS1/CDKN2 and cyclin Dl/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3:2229-2236
39. Van de Putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R (2004) Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol Oncol 92:40-46
40. Volm M, Koomagi R, Mattern J, Stammler G (1997) Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 75:1774-1778
41. Wright TC, Ferenczy A, Kurman RJ (2002) Carcinoma and other tumors of the cervix. In: Kurman RJ (ed) Blaustein's pathology of the female genital tract, 5th edn. Springer, Berlin Heidelberg New York, pp 325-346
42. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C (2003) E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn 3:617-633
43. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Durr P (1995) Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 69:6389-6399
44. Zhai YL, Nikaido T, Shiozawa T, Orii A, Fujii S (1999) Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. Int J Cancer 84:244-250